Abstract
Alterations in fluid and electrolyte balance represent a common complaint by women during different stages of the menstrual cycle; however, conflicting results concerning the possible role of plasma Atrial Natriuretic Peptide (ANP) modifications during the menstrual cycle have been reported. This may be due to differences in assay methods or in the clinical protocol adopted. Moreover, possible variations in plasma Brain Natriuretic Peptide (BNP) levels during the menstrual cycle have not been studied. We measured the plasma levels of ANP and BNP by means of two highly sensitive and specific immunoradiometric assay (IRMA) methods in 19 normal women without premenstrual symptoms, in order to evaluate whether significant modifications of these hormones are present during the menstrual cycle. Because it is well-known that circulating levels of cardiac hormones show great variations in normal subjects due to their rapid plasma half lifes, blood samples were collected at 2.5-min intervals over a 15-min period on the 5th and 24th days of the cycle. The mean (±SD) values of ANP (follicular phase=15.1±8.7 pg/ml; luteal phase=14.8±9.5 pg/ml) and of BNP (follicular phase=13.0±15.0 pg/ml; luteal phase= 11.2±11.4 pg/ml) did not show significant variations during the menstrual cycle. Moreover, the variability of ANP values (CV=24.8±13.2%) was significantly higher (p=0.0318) than that of BNP values (CV=16.5±8.9%), and a significant correlation was found between the mean ANP and BNP values of the individual women studied (R=0.407, p=0.0437). The values of estradiol, progesterone, LH, FSH and prolactin did not correlate with the ANP or BNP values. In conclusion, our results indicate that circulating levels of cardiac hormones do not show any significant modifications during the menstrual cycle in healthy women.
Similar content being viewed by others
References
De Bold A.J. Atrial natriuretic factor: a hormone produced by the heart. Science 230: 767, 1985.
Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol. Rev. 44: 479, 1992.
Espiner E.A. Hormones of the cardiovascular system. In: DeGroot L.J. (Eds.), Endocrinology, 3rd ed. W.B. Saunders Company, USA, 1995 p. 2895.
Paller M.S., Ferris T.F. Fluid and electrolyte metabolism during pregnancy. In: Narins R.G. (Ed.), Clinical disorders of fluid and electrolyte metabolism, fifth Edition. McGraw-Hill, Inc., New York, 1994, p. 1121.
Irons D.W., Bayles P.H., Davison J.M. Effect of atrial natriuretic peptide on renal hemodynamics and sodium excretion during human pregnancy. Am. J. Physiol. 271: F239, 1996.
Rutherford A.J., Anderson J.V., Elder M.G., Bloom S.R. Release of atrial natriuretic peptide during pregnancy and immediate puerperium. Lancet i: 928, 1987.
Øian P., Tollan A., Fadnes H.O., Noddeland H., Maltau J.M. Transcapillary fluid dynamics during the menstrual cycle. Am. J. Obstet. Gynecol. 156: 952, 1987.
Bisson D.L., Dunster G.D., O’Hare J.P., Hampton D., Penney M.D. Renal sodium retention does not occur during the luteal phase of the menstrual cycle in normal women. Br. J. Obstet. Gynaecol. 99: 247, 1992.
Tan A.C.I.T.L., Rosmalen F.M.A., Theelen B.G.A., Kloppenborg P.W.C., Benraad H.B., Benraad T.J. Atrial natriuretic peptide the influence of various physiological and sampling conditions. Ann. Clin. Biochem. 24: 500, 1987.
Jensen L.K., Svanegaard J., Husby H. Atrial natriuretic peptide during menstrual cycle. Am. J. Obstet. Gynecol. 161: 951, 1989.
Clark B.A., Elahi D., Epstein F.H. The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide. J. Clin. Endocrinol. Metab. 70: 349, 1990.
Yeko T.R., Rao P.S., Parsons A.K., Mayer J.C., Graham L.B., Maroulis G.B. Atrial natriuretic peptide, oestradiol and progesterone in women undergoing spontaneous and gonadotropin-stimulated ovulatory cycles. Hum. Reprod. 10: 2872, 1995.
Trigoso W.F., Wesly J.M., Meranda D.L., Shenker Y. Vasopressin and atrial natriuretic hormone response to hypertonic saline during the follicular and luteal phases of the menstrual cycle. Hum. Reprod. 11: 2392, 1996.
Clerico A., Del Chicca M.G., Giganti M., Zucchelli G.C., Piffanelli A. Evaluation and comparis of the analytical performances of two RIA kits for the assay of atrial natriuretic peptides (ANP). J. Nucl. Med. Allied. Sci.34: 81, 1990.
Clerico A., Opocher G., Pelizzola D., Panzali A.F., Andreone P., Del Chicca M.G., Giganti M., Zucchelli C.G., Mantero F., Albertini A., Piffanelli A. Evaluation of the analytical performance of RIA methods for measurement of Atrial Natriuretic Peptides (ANP): a multicentre study. J. Clin. Immunoassay 14: 251, 1991.
Clerico A., Iervasi G., Del Chicca M.G., Maffei S., Berti S., Sabatino L., Turchi S., Cazzuola F., Manfredi C., Biagini A. Analytical performance and clinical usefulness of a commercially available IRMA kit for the measurement of atrial natriuretic peptide in patients with heart failure. Clin. Chem. 42: 1627, 1996.
Clerico A., Iervasi G., Del Chicca M.G., Emdin M., Maffei S., Nannipieri M., Sabatino L., Forini F., Manfredi C., Donato L. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J. Endocrinol. Invest. 21: 170, 1998.
Iervasi G., Clerico A., Berti S., Pilo A., Vitek F., Biagini A., Baratto M.T., Bianchi R., Donato L. ANP kinetics in normal men: in vivo measurement by a tracer method and correlation with sodium intake. Am. J. Physiol. 264: F480, 1993.
Clerico A., Iervasi G., Berti S., Pilo A., Vitek F., Salvadori S., Marastoni M., Manfredi C., Del Chicca M.G., Iascone M.R., Biagini A. In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans. J. Endocrinol. Invest. 18: 194, 1995.
Iervasi G., Clerico A., Berti S., Pilo A., Biagini A., Bianchi R., Donato L. Altered tissue degradation and distribution of Atrial Natriuretic Peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling. Circulation 91: 2018, 1995.
Nugent A.M., Onuoha G.N., McEneaney D.J., Steele I.C., Hunter S.J., Prasanna K., Campbell N.P., Shaw C., Buchanan K.D., Nicholls D.P. Variable patterns of atrial natriuretic peptide secretion in man. Eur. J. Clin. Invest. 24: 267, 1994.
Pilo A., Iervasi G., Clerico A., Vitek F., Berti S., Palmieri C., Biagini A., Donato L. The circulatory model in metabolic studies of rapidly renewed hormones: application to ANP kinetics. Am. J. Physiol. 274: E560, 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maffei, S., Clerico, A., Iervasi, G. et al. Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle. J Endocrinol Invest 22, 1–5 (1999). https://doi.org/10.1007/BF03345470
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345470